We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

71 hedge funds and large institutions have $767M invested in Legend Biotech in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 12

54% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 13

16% more funds holding

Funds holding: 61 → 71 (+10)

6% more capital invested

Capital invested by funds: $723M → $767M (+$43.8M)

0.36% more ownership

Funds ownership: 9.65% → 10.01% (+0.36%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

69% less call options, than puts

Call options by funds: $263K | Put options by funds: $836K

Holders
71
Holders Change
+10
Holders Change %
+16.39%
% of All Funds
1.25%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
22
Increased
20
Reduced
13
Closed
12
Calls
$263K
Puts
$836K
Net Calls
-$573K
Net Calls Change
-$573K

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$44.7M
2
CCM
Consonance Capital Management
New York
+$24.5M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$24.3M
4
Artisan Partners
Artisan Partners
Wisconsin
+$23M
5
MWNA
Marshall Wace North America
New York
+$11.2M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$67.8M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$19.1M
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$15.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$12.4M
5
WP
Woodline Partners
California
-$12.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
VC
1
Vivo Capital
California
$80M – – –
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$62.9M -$15.5M -567,932 -21%
AllianceBernstein
3
AllianceBernstein
Tennessee
$61.5M +$24.3M +890,832 +72%
Federated Hermes
4
Federated Hermes
Pennsylvania
$61.1M +$6.93M +253,978 +14%
CII
5
Capital International Inc
California
$55.6M – – –
Point72 Asset Management
6
Point72 Asset Management
Connecticut
$47.6M +$44.7M +1,639,200 New
JJIJ
7
Johnson & Johnson Innovation - JJDC
New Jersey
$47.3M – – –
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$37.7M -$19.1M -700,000 -35%
Capital World Investors
9
Capital World Investors
California
$34.6M – – –
MICM
10
Matthews International Capital Management
California
$30.6M +$7.61M +279,000 +36%
CCM
11
Consonance Capital Management
New York
$26M +$24.5M +896,608 New
Artisan Partners
12
Artisan Partners
Wisconsin
$24.5M +$23M +845,048 New
Capital International Investors
13
Capital International Investors
California
$19.3M -$752K -27,570 -4%
HA
14
HHLR Advisors
Cayman Islands
$18.9M – – –
BG
15
Bellevue Group
Switzerland
$17.5M +$5.1M +186,902 +45%
Citadel Advisors
16
Citadel Advisors
Florida
$17.3M +$9.82M +360,065 +152%
Franklin Resources
17
Franklin Resources
California
$14.4M -$9.41M -345,086 -41%
MWNA
18
Marshall Wace North America
New York
$11.9M +$11.2M +410,836 New
FFM
19
FengHe Fund Management
Singapore
$10.8M +$2.83M +103,917 +39%
Manulife (Manufacturers Life Insurance)
20
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$9.56M +$8.98M +329,368 New
RSCM
21
Rock Springs Capital Management
Maryland
$9.07M +$87.3K +3,200 +1%
NHAS
22
Novo Holdings A/S
Denmark
$7.38M +$6.93M +254,176 New
AA
23
ALPS Advisors
Colorado
$6.93M +$6.22K +228 +0.1%
BlackRock
24
BlackRock
New York
$6.07M +$450K +16,507 +9%
YRHAM
25
Yong Rong (HK) Asset Management
Hong Kong
$5.76M – – –
1
2 3 4

LEGN Hedge Fund Activity: Q1 2021 in Review

71 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q1 2021, worth a combined $767M — up 6.1% from $723M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new LEGN positions and 12 closed out — a net gain of 10 holders — while 20 added to existing stakes and 13 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $44.7M. The largest seller was RA Capital Management, exiting entirely with an estimated $67.8M sold.

  • 71 institutional investors held Legend Biotech (LEGN) as of Q1 2021, up from 61 in Q4 2020.
  • Funds reported $767M of Legend Biotech stock for Q1 2021, up 6.1% quarter-over-quarter.
  • 22 funds opened new Legend Biotech positions in Q1 2021 and 12 closed out, a net change of +10 holders.
  • The largest Legend Biotech buyer in Q1 2021 was Point72 Asset Management, an estimated $44.7M added.
  • The largest Legend Biotech seller in Q1 2021 was RA Capital Management, an estimated $67.8M sold.

Based on aggregated 13F filings for Q1 2021.